Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
Sun Mi Hwang, Min Sun Kim, Dae-Yeol Lee
Ann Pediatr Endocrinol Metab. 2016;21(2):70-74.   Published online 2016 Jun 30     DOI: https://doi.org/10.6065/apem.2016.21.2.70
Citations to this article as recorded by Crossref logo
Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
Ari Song, Su Jin Kim, Min-Sun Kim, Jiyeon Kim, Insung Kim, Ga Young Bae, Eunseop Seo, Young Seok Cho, Joon Young Choi, Sung Yoon Cho, Dong-Kyu Jin
Frontiers in Endocrinology.2021;[Epub]     CrossRef
Long-Term Antithyroid Treatment in Pediatric and Juvenile Graves’ Disease
Hossein Delshad, Miralireza Takyar
International Journal of Endocrinology and Metabolism.2020;[Epub]     CrossRef
Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong
Endocrinology and Metabolism.2019; 34(3): 268.     CrossRef